Can Omega-3 and black seed oil help beat COVID-19?
NCT ID NCT04553705
First seen Jun 26, 2026 ยท Last updated Jun 26, 2026
Summary
This completed trial tested whether natural supplements like omega-3, black seed oil, Indian costus, and quinine could boost the immune system of 150 COVID-19 patients. Participants had mild to moderate symptoms and were monitored for recovery time, fever, lung inflammation, and other health markers. The goal was to see if these supplements could help the body fight the virus and reduce hospital stays.
What this could mean
Our plain-language read of the trial. This is informational only โ not medical advice or a prediction.
- Active substance
- Omega-3, black seed oil, Indian costus, quinine pills
- What this could lead to
- If effective, these supplements could help the immune system fight COVID-19 and speed recovery.
- What could go wrong
- This is a small, completed trial with no published results yet. Supplements are not a proven treatment and may not work for everyone.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COVID19 are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Maternity and Children hospital
Mecca, Mecca Region, Saudi Arabia
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a different way of pedaling rebuild muscles after severe COVID-19?
- Ancient herbs take on long COVID: a trial tests whether chinese medicine can soothe persistent fatigue
- Can a 15-Minute chat at a testing site boost COVID-19 vaccination?
- E-Ink screens in ERs could boost patient satisfaction
- Massive study tracks how lockdowns shaped mental health across america
- Hidden danger: study probes blood clot risk in cancer patients with COVID-19